TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T53024	Somatostatin receptor type 2	B3MGP9	3-(4-Piperidinophenyl)-1-[3-[(5-bromo-2-pyridinyl)(3,4-dichlorobenzyl)amino]propyl]thiourea	Investigative	10793795	C27H30BrCl2N5S	607.4	C1CCN(CC1)C2=CC=C(C=C2)NC(=S)NCCCN(CC3=CC(=C(C=C3)Cl)Cl)C4=NC=C(C=C4)Br	Ki > 300000 nM	Non binder
T53024	Somatostatin receptor type 2	B80KAD	3-[3-(2-Pyridinylamino)propyl]-1-[3-[(5-bromo-2-pyridinyl)(3,4-dichlorobenzyl)amino]propyl]thiourea	Investigative	10698494	C24H27BrCl2N6S	582.4	C1=CC=NC(=C1)NCCCNC(=S)NCCCN(CC2=CC(=C(C=C2)Cl)Cl)C3=NC=C(C=C3)Br	Ki > 300000 nM	Non binder
T53024	Somatostatin receptor type 2	B8RP3A	3-(3-Phenylpropyl)-1-[4-[(2-pyridinyl)(4-bromobenzyl)amino]butyl]thiourea	Investigative	44361984	C26H31BrN4S	511.5	C1=CC=C(C=C1)CCCNC(=S)NCCCCN(CC2=CC=C(C=C2)Br)C3=CC=CC=N3	Ki > 300000 nM	Non binder
T53024	Somatostatin receptor type 2	B9DF6W	3-(4-Piperidinophenyl)-1-[2-[(5-bromo-2-pyridinyl)(3,4-dichlorobenzyl)amino]ethyl]thiourea	Investigative	10698706	C26H28BrCl2N5S	593.4	C1CCN(CC1)C2=CC=C(C=C2)NC(=S)NCCN(CC3=CC(=C(C=C3)Cl)Cl)C4=NC=C(C=C4)Br	Ki > 300000 nM	Non binder
T53024	Somatostatin receptor type 2	BI07WR	3-(1H-Benzimidazole-2-ylmethyl)-1-[2-[(5-bromo-2-pyridinyl)(3,4-dichlorobenzyl)amino]ethyl]thiourea	Investigative	10603005	C23H21BrCl2N6S	564.3	C1=CC=C2C(=C1)NC(=N2)CNC(=S)NCCN(CC3=CC(=C(C=C3)Cl)Cl)C4=NC=C(C=C4)Br	Ki > 300000 nM	Non binder